The desperate need for good-quality clinical trials to evaluate the optimal source and dose of fibrinogen in managing bleeding
-
* Corresponding author: Beverley J Hunt beverley.hunt@gstt.nhs.uk
Critical Care 2011, 15:1006 doi:10.1186/cc10510
See related research by Kozek-Langenecker et al., http://ccforum.com/content/15/5/R239 and related letter by Kozek-Langenecker et al., http://ccforum.com/content/15/6/462.
Accesses
- Last 30 days: 47 accesses
- Last 365 days: 1171 accesses
- All time: 1171 accesses
Cited by
BioMed Central: 1 citation
|
Letter
Emotional or evidence-based medicine: is there a moral tragedy in haemostatic therapy? Sibylle Kozek-Langenecker, Benny Sørensen, John Hess, Donat R Spahn Critical Care 2011, 15:462 (29 December 2011) |
